-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Guideline Implementation Champions

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Workforce, Diseases, Therapies, Adverse Events, Technology and Procedures
Sunday, December 11, 2022: 9:30 AM-11:00 AM
353-355 (Ernest N. Morial Convention Center)

Lecture Title:
ASH Guideline Implementation to Improve Pain Management of Sickle Cell Disease

Rachel P. Rosovsky, MD, Massachusetts General Hospital
Rosovsky: Penumbra: Consultancy; Inari: Consultancy; Janssen: Consultancy; BMS: Consultancy; dova: Consultancy; abbott: Consultancy.
This session, led by Dr. Rachel Rosovsky, recognizes practitioners who are working to implement evidence-based guideline recommendations at the point of care in their clinical settings.    

Jori E. May and colleagues observed frequent deviation from guideline-supported care in patients with suspicion for and with confirmed heparin-induced thrombocytopenia (HIT). In response, they developed an electronic consultation (e-consultation) system (the “HIT E-consult Service”), in which a hematologist was automatically consulted on all patients with a positive screening immunoassay for HIT.  

Jordan Schaefer and colleagues participated in a quality improvement project starting between October of 2017 and June of 2018 at six diverse clinical sites. They were able to implement an ASH guideline recommendation to reduce excess aspirin use among patients anticoagulated for VTE and sustain this effort over several years.  

Andres Vasconez Samaniego and colleagues investigated the average time to first analgesic dose delivery in the Pediatric ED to patients with Sickle Cell Disease SCD vaso-occlusive pain events and found it was higher than the national recommendation. The most current guidelines from the National Heart Lung Blood Institute and ASH were utilized to streamline pain management in the Pediatric Emergency Department.

Jori E. May, MD

Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL

Jordan K Schaefer, MD

Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI

W. Andres Vasconez Samaniego, MD

Pediatric Oncology Branch, Johns Hopkins University/NIH National Cancer Institute, Columbia, MD